|Issuer:||SEELOS THERAPEUTICS, INC. (SEEL)|
|Original Submission Date:|
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR NEW YORK, NY 10022
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||the price reported in column 4 is a weighted average purchase price. these shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. the reporting person undertakes to provide to the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares acquired at each separate price.|